BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35202959)

  • 1. Serum glypican-4 is a marker of future vascular risk and mortality in coronary angiography patients.
    Muendlein A; Brandtner EM; Leiherer A; Geiger K; Heinzle C; Gaenger S; Fraunberger P; Mader A; Saely CH; Drexel H
    Atherosclerosis; 2022 Mar; 345():33-38. PubMed ID: 35202959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum glypican-4 is associated with the 10-year clinical outcome of patients with peripheral artery disease.
    Muendlein A; Heinzle C; Leiherer A; Geiger K; Brandtner EM; Gaenger S; Fraunberger P; Saely CH; Drexel H
    Int J Cardiol; 2022 Dec; 369():54-59. PubMed ID: 35944770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating glypican-4 is a new predictor of all-cause mortality in patients with heart failure.
    Muendlein A; Heinzle C; Leiherer A; Brandtner EM; Geiger K; Gaenger S; Fraunberger P; Mader A; Saely CH; Drexel H
    Clin Biochem; 2023 Nov; 121-122():110675. PubMed ID: 37844682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiography.
    Muendlein A; Brandtner EM; Leiherer A; Geiger K; Heinzle C; Gaenger S; Fraunberger P; Mader A; Saely CH; Drexel H
    Data Brief; 2022 Jun; 42():108142. PubMed ID: 35496482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the association of serum glypican-4 with prevalent and future kidney function.
    Muendlein A; Brandtner EM; Leiherer A; Geiger K; Heinzle C; Gaenger S; Fraunberger P; Haider D; Saely CH; Drexel H
    Sci Rep; 2022 Jun; 12(1):10168. PubMed ID: 35715556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients.
    Muendlein A; Severgnini L; Decker T; Heinzle C; Leiherer A; Geiger K; Drexel H; Winder T; Reimann P; Mayer F; Nonnenbroich C; Dechow T
    Front Oncol; 2022; 12():1045995. PubMed ID: 36353562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Glypican-4 Is a Predictor of 24-Month Overall Survival in Metastatic Breast Cancer.
    Muendlein A; Heinzle C; Brandtner EM; Leiherer A; Drexel H; Dechow T; Decker T
    Oncol Res Treat; 2023; 46(4):151-156. PubMed ID: 36750040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum glypican 4 level in obese children and its relation to degree of obesity.
    Leelalertlauw C; Korwutthikulrangsri M; Mahachoklertwattana P; Chanprasertyothin S; Khlairit P; Pongratanakul S; Poomthavorn P
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):689-695. PubMed ID: 28746787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changes of serum glypican4 in obese patients with different glucose metabolism status.
    Zhu HJ; Pan H; Cui Y; Wang XQ; Wang LJ; Li NS; Yang HB; Gong FY
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2697-701. PubMed ID: 25144630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum glypican4 and glycosylphosphatidylinositol-specific phospholipase D levels are associated with adipose tissue insulin resistance in obese subjects with different glucose metabolism status.
    Zhang K; Zhu H; Wang L; Yang H; Pan H; Gong F
    J Endocrinol Invest; 2021 Apr; 44(4):781-790. PubMed ID: 32816247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Triglycerides to High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio Predicts Long-Term Mortality in High-Risk Patients.
    Sultani R; Tong DC; Peverelle M; Lee YS; Baradi A; Wilson AM
    Heart Lung Circ; 2020 Mar; 29(3):414-421. PubMed ID: 31014557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of serum glypican-4 levels with cardiovascular risk predictors in women with polycystic ovary syndrome - a pilot study.
    Jędrzejuk D; Lwow F; Kuliczkowska-Płaksej J; Hirnle L; Trzmiel-Bira A; Lenarcik-Kabza A; Kolackov K; Łaczmański Ł; Milewicz A
    Gynecol Endocrinol; 2016; 32(3):223-6. PubMed ID: 26486309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Glypican-4 Level with Basal Active Glucagon-Like Peptide 1 Level in Patients with Type 2 Diabetes Mellitus.
    Lee SA; Koh G; Cho SJ; Yoo SY; Chin SO
    Endocrinol Metab (Seoul); 2016 Sep; 31(3):439-445. PubMed ID: 27704740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary report on the prognostic significance of preoperative brain natriuretic peptide and postoperative cardiac troponin in patients undergoing major vascular surgery.
    Bolliger D; Seeberger MD; Lurati Buse GA; Christen P; Rupinski B; Gürke L; Filipovic M
    Anesth Analg; 2009 Apr; 108(4):1069-75. PubMed ID: 19299763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct Characteristics of VEGF-D and VEGF-C to Predict Mortality in Patients With Suspected or Known Coronary Artery Disease.
    Wada H; Suzuki M; Matsuda M; Ajiro Y; Shinozaki T; Sakagami S; Yonezawa K; Shimizu M; Funada J; Takenaka T; Morita Y; Nakamura T; Fujimoto K; Matsubara H; Kato T; Unoki T; Takagi D; Wada K; Wada M; Iguchi M; Masunaga N; Ishii M; Yamakage H; Kusakabe T; Yasoda A; Shimatsu A; Kotani K; Satoh-Asahara N; Abe M; Akao M; Hasegawa K;
    J Am Heart Assoc; 2020 May; 9(9):e015761. PubMed ID: 32319336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting risk of coronary events and all-cause mortality: role of B-type natriuretic peptide above traditional risk factors and coronary artery calcium scoring in the general population: the Heinz Nixdorf Recall Study.
    Kara K; Mahabadi AA; Berg MH; Lehmann N; Möhlenkamp S; Kälsch H; Bauer M; Moebus S; Dragano N; Jöckel KH; Neumann T; Erbel R
    Eur J Prev Cardiol; 2014 Sep; 21(9):1171-9. PubMed ID: 23674833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome.
    Veugelers M; Vermeesch J; Watanabe K; Yamaguchi Y; Marynen P; David G
    Genomics; 1998 Oct; 53(1):1-11. PubMed ID: 9787072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toe brachial index predicts major acute cardiovascular events in patients with type 2 diabetes independently of arterial stiffness.
    Chisalita SI; Wijkman M; Davidson LT; Spångeus A; Nyström F; Östgren CJ
    Diabetes Res Clin Pract; 2020 Mar; 161():108040. PubMed ID: 32006647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Predictive Value of Coronary Artery Calcium Scoring for Major Adverse Cardiac Events According to Renal Function (from the Coronary Computed Tomography Angiography Evaluation for Clinical Outcomes: An International Multicenter [CONFIRM] Registry).
    Lee JH; Rizvi A; Hartaigh BÓ; Han D; Park MW; Roudsari HM; Stuijfzand WJ; Gransar H; Lu Y; Callister TQ; Berman DS; DeLago A; Hadamitzky M; Hausleiter J; Al-Mallah MH; Budoff MJ; Kaufmann PA; Raff GL; Chinnaiyan K; Cademartiri F; Maffei E; Villines TC; Kim YJ; Leipsic J; Feuchtner G; Pontone G; Andreini D; Marques H; de Araújo Gonçalves P; Rubinshtein R; Achenbach S; Shaw LJ; Chow BJW; Cury RC; Bax JJ; Chang HJ; Jones EC; Lin FY; Min JK; Peña JM
    Am J Cardiol; 2019 May; 123(9):1435-1442. PubMed ID: 30850210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor long-term outcomes in stroke patients with asymptomatic coronary artery disease in heart CT.
    Yoo J; Song D; Baek JH; Kim K; Kim J; Song TJ; Lee HS; Choi D; Kim YD; Nam HS; Heo JH
    Atherosclerosis; 2017 Oct; 265():7-13. PubMed ID: 28825975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.